G-Protein Coupled Receptors
G-protein coupled receptors are the largest family of drug targets, mediating diverse physiological responses through G-protein signaling and second messengers. This article covers their structure, signaling, and regulation.
Table of Contents
Structural Overview
G-protein coupled receptors (GPCRs) are seven-transmembrane domain receptors. Each receptor has seven alpha-helical segments that span the plasma membrane, connected by three extracellular and three intracellular loops. The extracellular side receives the signal, while the intracellular side interacts with G-proteins and other signaling components.
GPCRs represent approximately 4 percent of the human genome, with over 800 members. They respond to an extraordinary range of stimuli: light, ions, small molecules, lipids, peptides, and proteins.
G-Protein Signaling Mechanism
The signaling cascade follows a conserved pattern:
- Ligand binding: An agonist binds the extracellular or transmembrane domain.
- Conformational change: The receptor undergoes a structural shift transmitted across the membrane.
- G-protein activation: The receptor acts as a guanine nucleotide exchange factor (GEF), catalyzing the exchange of GDP for GTP on the G-alpha subunit.
- Subunit dissociation: The GTP-bound G-alpha subunit separates from the G-beta-gamma dimer.
- Effector regulation: Both G-alpha and G-beta-gamma modulate downstream effectors.
- Signal termination: Intrinsic GTPase activity of G-alpha hydrolyzes GTP to GDP, reassembling the inactive heterotrimer.
Second Messengers
G-proteins generate diverse second messengers depending on their subtype:
- Gs stimulates adenylyl cyclase: Increases cyclic AMP (cAMP), activating protein kinase A (PKA).
- Gi inhibits adenylyl cyclase: Decreases cAMP.
- Gq activates phospholipase C: Cleaves PIP2 into IP3 (releases calcium from ER) and DAG (activates protein kinase C).
Mnemonic: “Gs is a stimulator (S for stimulating cAMP), Gi is an inhibitor, Gq triggers the q-ualifier question (calcium release).”
Receptor Desensitization
Prolonged agonist exposure reduces receptor responsiveness through multiple mechanisms:
- Phosphorylation: GRKs (G-protein-coupled receptor kinases) phosphorylate the activated receptor.
- Arrestin binding: Beta-arrestin binds phosphorylated receptors, blocking G-protein coupling and targeting receptors for internalization via clathrin-coated pits.
- Receptor internalization: Endocytosed receptors may be recycled to the membrane or degraded in lysosomes.
This regulatory mechanism prevents overstimulation and is critical for understanding drug tolerance.
Therapeutic Significance
GPCRs are the target of approximately 34 percent of FDA-approved drugs. Therapeutic applications span nearly every organ system, from beta-blockers in cardiovascular disease to antihistamines in allergy management. Peptide-based GPCR ligands represent a growing area of drug development, with advantages including high selectivity and potency.